APO RESEARCH · REPORT
Metformin Hydrochloride
Metformin hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents.
Product & engineering
Understand the product.
Metformin hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents.
Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5·HCL and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether and chloroform.
In this report, our statistics is given by metformin hydrochloride API.
Selected research
Market Structure
Global Metformin Hydrochloride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Metformin hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents.
Metformin hydrochloride is a white to off-white crystalline compound with a molecular formula of C4H11N5·HCL and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether and chloroform.
In this report, our statistics is given by metformin hydrochloride API.
Read the full market overview
Asia-Pacific is the largest market with about 60% revenue market share. Followed by Europe, accounting for about 17% revenue market share.
The key players are Wanbury, USV, Exemed Pharmaceuticals, Vistin Pharma, Aarti Drugs, Farmhispania Group, Harman Finochem, Shijiazhuang Polee Pharmaceutical, Keyuan Pharmaceutical, CR Double-Crane, Shouguang Fukang Pharmaceutical etc. USV is the largest manufacturer with about 26% revenue market share.
The report provides an overview of the global Metformin Hydrochloride market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Metformin Hydrochloride and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Metformin Hydrochloride sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Metformin Hydrochloride market size, projected growth trends, production technologies, key applications, and end-use industries.
Metformin Hydrochloride Segment by Company
Wanbury
USV
Exemed Pharmaceuticals
Vistin Pharma
Aarti Drugs
Farmhispania Group
Harman Finochem
Shijiazhuang Polee Pharmaceutical
Keyuan Pharmaceutical
CR Double-Crane
Shouguang Fukang Pharmaceutical
Metformin Hydrochloride Segment by Type
Metformin HCL
Metformin DC
Others
Metformin Hydrochloride Segment by Application
Metformin Hydrochloride Tablets
Metformin Hydrochloride Extended-Release Tablets
Others
Metformin Hydrochloride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metformin Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metformin Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metformin Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Metformin Hydrochloride market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Metformin Hydrochloride industry.
Chapter 3: Detailed analysis of Metformin Hydrochloride market competition landscape. Including Metformin Hydrochloride manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Metformin Hydrochloride by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Metformin Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Metformin HCL
- Metformin DC
- Others
Applications
- Metformin Hydrochloride Tablets
- Metformin Hydrochloride Extended-Release Tablets
- Others
Companies covered
- Wanbury
- USV
- Exemed Pharmaceuticals
- Vistin Pharma
- Aarti Drugs
- Farmhispania Group
- Harman Finochem
- Shijiazhuang Polee Pharmaceutical
- Keyuan Pharmaceutical
- CR Double-Crane
- Shouguang Fukang Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Metformin Hydrochloride Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Metformin Hydrochloride Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Metformin Hydrochloride Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Metformin Hydrochloride Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Metformin Hydrochloride Market Dynamics
- 2.1 Metformin Hydrochloride Industry Trends
- 2.2 Metformin Hydrochloride Industry Drivers
- 2.3 Metformin Hydrochloride Industry Opportunities and Challenges
- 2.4 Metformin Hydrochloride Industry Restraints
3 Metformin Hydrochloride Market by Manufacturers
- 3.1 Global Metformin Hydrochloride Production Value by Manufacturers (2021-2026)
- 3.2 Global Metformin Hydrochloride Production by Manufacturers (2021-2026)
- 3.3 Global Metformin Hydrochloride Average Price by Manufacturers (2021-2026)
- 3.4 Global Metformin Hydrochloride Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Metformin Hydrochloride Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Metformin Hydrochloride Manufacturers, Product Type & Application
- 3.7 Global Metformin Hydrochloride Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Metformin Hydrochloride Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Metformin Hydrochloride Players Market Share by Production Value in 2025
- 3.8.3 2025 Metformin Hydrochloride Tier 1, Tier 2, and Tier 3
4 Metformin Hydrochloride Market by Type
- 4.1 Metformin Hydrochloride Type Introduction
- 4.1.1 Metformin HCL
- 4.1.2 Metformin DC
- 4.1.3 Others
- 4.2 Global Metformin Hydrochloride Production by Type
- 4.2.1 Global Metformin Hydrochloride Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Metformin Hydrochloride Production by Type (2021-2032)
- 4.2.3 Global Metformin Hydrochloride Production Market Share by Type (2021-2032)
- 4.3 Global Metformin Hydrochloride Production Value by Type
- 4.3.1 Global Metformin Hydrochloride Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Metformin Hydrochloride Production Value by Type (2021-2032)
- 4.3.3 Global Metformin Hydrochloride Production Value Market Share by Type (2021-2032)
5 Metformin Hydrochloride Market by Application
- 5.1 Metformin Hydrochloride Application Introduction
- 5.1.1 Metformin Hydrochloride Tablets
- 5.1.2 Metformin Hydrochloride Extended-Release Tablets
- 5.1.3 Others
- 5.2 Global Metformin Hydrochloride Production by Application
- 5.2.1 Global Metformin Hydrochloride Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Metformin Hydrochloride Production by Application (2021-2032)
- 5.2.3 Global Metformin Hydrochloride Production Market Share by Application (2021-2032)
- 5.3 Global Metformin Hydrochloride Production Value by Application
- 5.3.1 Global Metformin Hydrochloride Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Metformin Hydrochloride Production Value by Application (2021-2032)
- 5.3.3 Global Metformin Hydrochloride Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Wanbury
- 6.1.1 Wanbury Company Information
- 6.1.2 Wanbury Business Overview
- 6.1.3 Wanbury Metformin Hydrochloride Production, Value and Gross Margin (2021-2026)
- 6.1.4 Wanbury Metformin Hydrochloride Product Portfolio
- 6.1.5 Wanbury Recent Developments
- 6.2 USV
- 6.2.1 USV Company Information
- 6.2.2 USV Business Overview
- 6.2.3 USV Metformin Hydrochloride Production, Value and Gross Margin (2021-2026)
- 6.2.4 USV Metformin Hydrochloride Product Portfolio
- 6.2.5 USV Recent Developments
- 6.3 Exemed Pharmaceuticals
- 6.3.1 Exemed Pharmaceuticals Company Information
- 6.3.2 Exemed Pharmaceuticals Business Overview
- 6.3.3 Exemed Pharmaceuticals Metformin Hydrochloride Production, Value and Gross Margin (2021-2026)
- 6.3.4 Exemed Pharmaceuticals Metformin Hydrochloride Product Portfolio
- 6.3.5 Exemed Pharmaceuticals Recent Developments
- 6.4 Vistin Pharma
- 6.4.1 Vistin Pharma Company Information
- 6.4.2 Vistin Pharma Business Overview
- 6.4.3 Vistin Pharma Metformin Hydrochloride Production, Value and Gross Margin (2021-2026)
- 6.4.4 Vistin Pharma Metformin Hydrochloride Product Portfolio
- 6.4.5 Vistin Pharma Recent Developments
- 6.5 Aarti Drugs
- 6.5.1 Aarti Drugs Company Information
- 6.5.2 Aarti Drugs Business Overview
- 6.5.3 Aarti Drugs Metformin Hydrochloride Production, Value and Gross Margin (2021-2026)
- 6.5.4 Aarti Drugs Metformin Hydrochloride Product Portfolio
- 6.5.5 Aarti Drugs Recent Developments
- 6.6 Farmhispania Group
- 6.6.1 Farmhispania Group Company Information
- 6.6.2 Farmhispania Group Business Overview
- 6.6.3 Farmhispania Group Metformin Hydrochloride Production, Value and Gross Margin (2021-2026)
- 6.6.4 Farmhispania Group Metformin Hydrochloride Product Portfolio
- 6.6.5 Farmhispania Group Recent Developments
- 6.7 Harman Finochem
- 6.7.1 Harman Finochem Company Information
- 6.7.2 Harman Finochem Business Overview
- 6.7.3 Harman Finochem Metformin Hydrochloride Production, Value and Gross Margin (2021-2026)
- 6.7.4 Harman Finochem Metformin Hydrochloride Product Portfolio
- 6.7.5 Harman Finochem Recent Developments
- 6.8 Shijiazhuang Polee Pharmaceutical
- 6.8.1 Shijiazhuang Polee Pharmaceutical Company Information
- 6.8.2 Shijiazhuang Polee Pharmaceutical Business Overview
- 6.8.3 Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Production, Value and Gross Margin (2021-2026)
- 6.8.4 Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Product Portfolio
- 6.8.5 Shijiazhuang Polee Pharmaceutical Recent Developments
- 6.9 Keyuan Pharmaceutical
- 6.9.1 Keyuan Pharmaceutical Company Information
- 6.9.2 Keyuan Pharmaceutical Business Overview
- 6.9.3 Keyuan Pharmaceutical Metformin Hydrochloride Production, Value and Gross Margin (2021-2026)
- 6.9.4 Keyuan Pharmaceutical Metformin Hydrochloride Product Portfolio
- 6.9.5 Keyuan Pharmaceutical Recent Developments
- 6.10 CR Double-Crane
- 6.10.1 CR Double-Crane Company Information
- 6.10.2 CR Double-Crane Business Overview
- 6.10.3 CR Double-Crane Metformin Hydrochloride Production, Value and Gross Margin (2021-2026)
- 6.10.4 CR Double-Crane Metformin Hydrochloride Product Portfolio
- 6.10.5 CR Double-Crane Recent Developments
- 6.11 Shouguang Fukang Pharmaceutical
- 6.11.1 Shouguang Fukang Pharmaceutical Company Information
- 6.11.2 Shouguang Fukang Pharmaceutical Business Overview
- 6.11.3 Shouguang Fukang Pharmaceutical Metformin Hydrochloride Production, Value and Gross Margin (2021-2026)
- 6.11.4 Shouguang Fukang Pharmaceutical Metformin Hydrochloride Product Portfolio
- 6.11.5 Shouguang Fukang Pharmaceutical Recent Developments
7 Global Metformin Hydrochloride Production by Region
- 7.1 Global Metformin Hydrochloride Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Metformin Hydrochloride Production by Region (2021-2032)
- 7.2.1 Global Metformin Hydrochloride Production by Region (2021-2026)
- 7.2.2 Global Metformin Hydrochloride Production Forecast by Region (2027-2032)
- 7.3 Global Metformin Hydrochloride Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Metformin Hydrochloride Production Value by Region (2021-2032)
- 7.4.1 Global Metformin Hydrochloride Production Value by Region (2021-2026)
- 7.4.2 Global Metformin Hydrochloride Production Value by Region (2027-2032)
- 7.5 Global Metformin Hydrochloride Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Metformin Hydrochloride Production Value (2021-2032)
- 7.6.2 Europe Metformin Hydrochloride Production Value (2021-2032)
- 7.6.3 Asia-Pacific Metformin Hydrochloride Production Value (2021-2032)
- 7.6.4 South America Metformin Hydrochloride Production Value (2021-2032)
- 7.6.5 Middle East & Africa Metformin Hydrochloride Production Value (2021-2032)
8 Global Metformin Hydrochloride Consumption by Region
- 8.1 Global Metformin Hydrochloride Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Metformin Hydrochloride Consumption by Region (2021-2032)
- 8.2.1 Global Metformin Hydrochloride Consumption by Region (2021-2026)
- 8.2.2 Global Metformin Hydrochloride Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Metformin Hydrochloride Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Metformin Hydrochloride Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Metformin Hydrochloride Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Metformin Hydrochloride Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Metformin Hydrochloride Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Metformin Hydrochloride Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Metformin Hydrochloride Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Metformin Hydrochloride Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Metformin Hydrochloride Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Metformin Hydrochloride Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Metformin Hydrochloride Value Chain Analysis
- 9.1.1 Metformin Hydrochloride Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Metformin Hydrochloride Production Mode & Process
- 9.2 Metformin Hydrochloride Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Metformin Hydrochloride Distributors
- 9.2.3 Metformin Hydrochloride Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst